|
 |
|
|
| |
Professor Stuart Hazell PhD (NSW), MASM, GAICD
Managing Director
Fusidium Pty Ltd.
Stuart has more than 30 years experience in biomedical science and applied research in the field of infectious disease. This background includes research, consulting within the biomedical industry and senior management at the level of Dean within the university sector.
In 2002 Stuart joined Panbio Ltd as Vice President, Research and Development. He was promoted to Chief Operating Officer in May 2005 and led a number of significant improvements in the manufacturing and operational areas of Panbio. In 2006 Stuart was appointed Acting Chief Executive Officer and formally became Chief Executive Officer in 2007. Stuart was actively involved in setting the strategic direction of Panbio with the company achieving profitable growth in financial years 2006 and 2007. Inverness Medical Innovations Inc. acquired Panbio in January 2008 for $42 million.
Stuart is currently the Managing Director of Fusidium Pty Ltd and is engaged in consulting activities with the biotechnology industry.
Stuart maintains an active involvement in the broader biomedical community. He is on the Industry Advisory Panel of the Faculty of Biological and Chemical Sciences at the University of Queensland and is member of the Board of Research Australia Ltd., an organisation engaged in promoting investment in basic and applied health and medical research.
|
|
| |
|
|
|
|